CSF1R and cancer: To determine the functional contribution of M-CSF and CD155 downregulation to carcinogen-induced cancer cell immunogenicity, we examined whether CSF1R and TIGIT blockade could lead to the rejection of DMBA3-4 + DMSO3-1 tumors in WT mice.